Utah 2025 Regular Session

Utah House Bill HB0558 Latest Draft

Bill / Introduced Version Filed 02/26/2025

                            02-26 12:26  H.B. 558
1 
Local Government Drug Testing Amendments
2025 GENERAL SESSION
STATE OF UTAH
Chief Sponsor: A. Cory Maloy
Senate Sponsor:
2 
 
3 
LONG TITLE
4 
General Description:
5 
This bill amends provisions relating to drug testing by government entities.
6 
Highlighted Provisions:
7 
This bill:
8 
▸ modifies the definition of "sample" to include oral fluid;
9 
▸ provides that a local government entity or state institution of higher education may
10 
require that a donor submit a blood, breath, oral fluid, hair, or urine sample for drug
11 
testing; and
12 
▸ modifies the requirement that an entity independent of the local governmental entity or
13 
state institution of higher education collect samples for drug testing by allowing a
14 
collection method that complies with instructions prepared by an independent entity.
15 
Money Appropriated in this Bill:
16 
None
17 
Other Special Clauses:
18 
None
19 
Utah Code Sections Affected:
20 
AMENDS:
21 
34-41-101, as last amended by Laws of Utah 2024, Chapter 352
22 
34-41-103, as repealed and reenacted by Laws of Utah 2024, Chapter 352
23 
34-41-104, as last amended by Laws of Utah 2024, Chapter 352
24 
 
25 
Be it enacted by the Legislature of the state of Utah:
26 
Section 1.  Section 34-41-101 is amended to read:
27 
34-41-101 . Definitions.
28 
      As used in this chapter:
29 
(1) "Donor" means an employee, a volunteer, a prospective employee, or a prospective
30 
volunteer of a local government entity or a state institution of higher education.
 H.B. 558  H.B. 558	02-26 12:26
31 
(2) "Drug" means any substance recognized as a drug in the United States Pharmacopeia,
32 
the National Formulary, the Homeopathic Pharmacopeia, or other drug compendia,
33 
including Title 58, Chapter 37, Utah Controlled Substances Act, or supplement to any of
34 
those compendia.
35 
(3) "Drug testing" means the scientific analysis for the presence of drugs or their
36 
metabolites in the human body in accordance with the definitions and terms of this
37 
chapter.
38 
(4) "Local governmental employee" means any person or officer in the service of a local
39 
governmental entity or state institution of higher education for compensation.
40 
(5)(a) "Local governmental entity" means any political subdivision of Utah including
41 
any county, municipality, local school district, special district, special service district,
42 
or any administrative subdivision of those entities.
43 
(b) "Local governmental entity" does not mean Utah state government or its
44 
administrative subdivisions provided for in Sections 63A-17-1001 through
45 
63A-17-1006.
46 
(6) "Periodic testing" means preselected and preannounced drug testing of employees or
47 
volunteers conducted on a regular schedule.
48 
(7) "Prospective employee" means any person who has made a written or oral application to
49 
become an employee of a local governmental entity or a state institution of higher
50 
education.
51 
(8) "Random testing" means the unannounced drug testing of an employee or volunteer
52 
who was selected for testing by using a method uninfluenced by any personal
53 
characteristics other than job category.
54 
(9) "Reasonable suspicion for drug testing" means an articulated belief based on the
55 
recorded specific facts and reasonable inferences drawn from those facts that a local
56 
government employee or volunteer is in violation of the drug-free workplace policy.
57 
(10) "Rehabilitation testing" means unannounced but preselected drug testing done as part
58 
of a program of counseling, education, and treatment of an employee or volunteer in
59 
conjunction with the drug-free workplace policy.
60 
(11) "Safety sensitive position" means any local governmental or state institution of higher
61 
education position involving duties which directly affects the safety of governmental
62 
employees, the general public, or positions where there is access to controlled
63 
substances, as defined in Title 58, Chapter 37, Utah Controlled Substances Act, during
64 
the course of performing job duties.
- 2 - 02-26 12:26  H.B. 558
65 
(12) "Sample" means urine, blood, breath, [saliva] oral fluid, or hair.
66 
(13) "State institution of higher education" means the institution as defined in Section
67 
53B-3-102.
68 
(14) "Volunteer" means any person who donates services as authorized by the local
69 
governmental entity or state institution of higher education without pay or other
70 
compensation except expenses actually and reasonably incurred.
71 
Section 2.  Section 34-41-103 is amended to read:
72 
34-41-103 . Policy requirements.
73 
(1)(a) A local governmental entity or a state institution of higher education may not test
74 
a donor for the presence of drugs, unless the local government entity or state
75 
institution of higher education:
76 
(i) adopts a written policy or ordinance for the testing;
77 
(ii) distributes the policy or ordinance to employees and volunteers; and
78 
(iii) makes the policy or ordinance available for review by prospective employees
79 
and prospective volunteers.
80 
(b) The local governmental entity or state institution of higher education may only test
81 
or retest for the presence of drugs in accordance with the policy or ordinance
82 
described in Subsection (1)(a).
83 
(2) The local government entity or state institution of higher education:
84 
(a) shall collect and test samples in accordance with Section 34-41-104; and
85 
(b) if otherwise permitted by law, is not limited only to collecting or testing in
86 
circumstances where there are indications of job-related impairment of an employee
87 
or volunteer.
88 
(3) The use and disposition of all drug test results are subject to the limitations of Title 63G,
89 
Chapter 2, Government Records Access and Management Act, and the Americans with
90 
Disabilities Act of 1990, 42 U.S.C. 12101 through 12213.
91 
(4) A donor who is subject to testing under a policy or ordinance described in Subsection
92 
(1)(a) shall:
93 
(a) submit [an oral] a blood, breath, oral fluid, or hair sample for testing; or
94 
(b) submit a split urine sample for testing or retesting.
95 
(5) Unless the policy or ordinance described in Subsection (1)(a) provides otherwise, the
96 
local governmental entity or state institution of higher education may specify the type of
97 
sample, described in Subsection (4), that the donor is required to submit.
98 
(6) A split urine sample shall consist of at least 45 milliliters of urine, divided into two
- 3 -  H.B. 558	02-26 12:26
99 
specimen bottles with:
100 
(a) at least 30 milliliters of urine in one bottle, for the initial test; and
101 
(b) at least 15 milliliters of urine in the other bottle for retesting, if requested under
102 
Subsection (7).
103 
(7) If the test results of a [urine or oral] sample test indicate the presence of drugs, the local
104 
governmental entity or state institution of higher education shall:
105 
(a) give notice to the donor:
106 
(i) of the test results; and
107 
(ii) for a urine test, that the donor may, within 72 hours after the local government
108 
entity or state institution of higher education provides the notice, request testing of
109 
the second sample; and
110 
(b) test the second sample if the donor timely requests testing of the second sample.
111 
(8) The expense of testing the second urine sample will be equally divided between the
112 
donor and the local governmental entity or state institution of higher education.
113 
(9) The test results of the samples shall be considered at any subsequent disciplinary
114 
hearing if the requirements of this section and Section 34-41-104 are complied with in
115 
the collection, handling, and testing of the samples.
116 
Section 3.  Section 34-41-104 is amended to read:
117 
34-41-104 . Requirements for identification, collection, and testing of samples.
118 
(1) The local governmental entity or state institution of higher education shall ensure that:
119 
(a) all sample collection under this chapter is performed in accordance with instructions
120 
prepared by an entity independent of the local government or state institution of
121 
higher education;
122 
(b) all testing for drugs under this chapter is performed by an independent laboratory
123 
certified for employment drug testing by either the Substance Abuse and Mental
124 
Health Services Administration or the College of American Pathology;
125 
(c) the instructions, chain of custody forms, and collection kits, including containers and
126 
seals, used for sample collection are prepared by an independent laboratory certified
127 
for employment drug testing by either the Substance Abuse and Mental Health
128 
Services Administration or the College of American Pathology; and
129 
(d) sample collection and testing for drugs under this chapter is in accordance with the
130 
requirements of this section.
131 
(2) The local governmental entity or state institution of higher education may:
132 
(a) in accordance with a policy or ordinance described in Subsection 34-41-103(1)(a),
- 4 - 02-26 12:26  H.B. 558
133 
require samples from a donor;
134 
(b) require presentation of reliable identification to the person collecting the samples; and
135 
(c) in order to dependably test for the presence of drugs, designate the type of sample to
136 
be used for testing.
137 
(3) The local governmental entity or state institution of higher education shall ensure that
138 
the local governmental entity's or state institution of higher education's ordinance or
139 
policy requires that:
140 
(a) the collection of samples is performed under reasonable and sanitary conditions;
141 
(b) samples are collected and tested:
142 
(i) to ensure the privacy of the individual being tested; and
143 
(ii) in a manner reasonably calculated to prevent substitutions or interference with the
144 
collection or testing of reliable samples;
145 
(c) sample collection is appropriately documented to ensure that:
146 
(i) samples are labeled and sealed to reasonably  preclude the probability of
147 
erroneous identification of test results; and
148 
(ii) a donor has the opportunity to provide notification of any information:
149 
(A) that a donor considers relevant to the test, including identification of currently
150 
or recently used prescription or nonprescription drugs or other relevant medical
151 
information; and
152 
(B) in compliance with the Americans with Disabilities Act of 1990, 42 U.S.C.
153 
12101 through 12213;
154 
(d) sample collection, storage, and transportation to the place of testing are performed in
155 
a manner that reasonably precludes the probability of sample misidentification,
156 
contamination, or adulteration; and
157 
(e) sample testing conforms to scientifically accepted analytical methods and procedures.
158 
(4) Before the result of any test may be used as a basis for any action by a local
159 
governmental entity or state institution of higher education under Section 34-41-105, the
160 
local governmental entity or state institution of higher education shall[ ]:
161 
(a) verify or confirm any positive initial screening test by gas chromatography, gas
162 
chromatography-mass spectroscopy, or other comparably reliable analytical methods;
163 
and
164 
(b) provide the notice described in Subsection 34-41-103(7), as soon as possible after a
165 
positive test result, at the last known address or telephone number of the donor.
166 
(5) [Any drug testing] Except for drug testing of a prospective employee or a prospective
- 5 -  H.B. 558	02-26 12:26
167 
volunteer, drug testing by a local governmental entity or state institution of higher
168 
education shall occur during or immediately after the regular work period of the
169 
employee or volunteer and shall be considered as work time for purposes of
170 
compensation and benefits.
171 
(6) The local governmental entity or state institution of higher education shall pay[ ] :
172 
(a) all costs of sample collection and initial testing for drugs required under the policy or
173 
ordinance described in Subsection 34-41-103(1)(a)[, ] ; and
174 
(b) [including the costs of transportation if the testing of an] if the donor is a current
175 
employee or current volunteer and testing is conducted at a place other than the
176 
workplace, the costs of transportation to the testing location.
177 
Section 4.  Effective Date.
178 
This bill takes effect on May 7, 2025.
- 6 -